Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

This study is ongoing, but not recruiting participants.

Study NCT00509041 Information provided by Cancer and Leukemia Group B

First Received: July 30, 2007 Last Updated: June 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	August 2013
Primary Completion Date:	February 2010 (Final data collection date for primary outcome measure)

Publications:

Dudek A, Pang H, Kratzke RA, et al.: CALGB 30601: A phase II study of dasatinib (D) in patients (pts) with previously treated malignant mesothelioma (MM). [Abstract] J Clin Oncol 28 (Suppl 15) A-7037, 2010.